Your next eye exam could be on your iPhone
NCT ID NCT06431295
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
Mayo Clinic is testing a new iPhone app called FaceScan that uses the phone's LiDAR sensor and voice recognition to measure how well you see. The study will enroll 150 adults to compare the app's results with standard vision tests. Researchers will also collect voice recordings of people reading letters to improve the app's speech recognition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VISUAL ACUITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FaceScan digital visual acuity device (iPhone app using LiDAR and voice processing)
What this could lead to
If successful, this could provide a convenient, at-home way to check vision using just an iPhone, potentially making eye screening more accessible.
What could go wrong
This is an early validation study with only 150 participants. The app may not be as accurate as standard clinical tests, and results may not apply to all ages or eye conditions.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.